Tag: licensing

  • A.L.M. Holding v. Zydex: Federal Circuit Clarifies Constitutional Standing for Patent Owners After Exclusive Licensing

    A.L.M. Holding v. Zydex: Federal Circuit Clarifies Constitutional Standing for Patent Owners After Exclusive Licensing

    The Federal Circuit’s recent decision in A.L.M. Holding Company v. Zydex Industries Private Ltd., Case No. 25-1317 (Fed. Cir. May 19, 2026), provides important clarification regarding constitutional standing in patent infringement suits where a patent owner has granted broad exclusive rights to a licensee but retained certain enforcement and economic interests.

    The opinion addresses a recurring issue in modern patent licensing structures: when does a patent owner retain enough rights to sue after entering into an exclusive license agreement? The Federal Circuit’s answer reinforces a distinction that district courts have sometimes blurred in recent years: Article III standing is not the same thing as statutory standing under 35 U.S.C. § 281.

    For patent owners, licensors, litigation funders, and companies structuring exclusive technology licenses, the case offers a roadmap for preserving enforceable rights while still granting substantial commercial authority to a licensee.

    The decision also continues the Federal Circuit’s recent effort to clean up years of confusion in standing doctrine following cases such as Morrow v. Microsoft, Lone Star Silicon Innovations v. Nanya, and Intellectual Tech LLC v. Zebra Technologies.

    The License Structure at Issue

    The patents involved related to warm-mix asphalt paving technologies (U.S. Patent Nos. 7,815,725;
    7,981,466; 9,394,652; 10,214,646; 8,734,581; and 9,175,446). A.L.M. Holding Company and Ergon Asphalt jointly owned the asserted patents and entered into an agreement granting Ingevity Corporation an “exclusive,” worldwide, royalty-bearing license to commercialize products under the patents.

    The agreement granted Ingevity broad commercial rights, including the right to manufacture, use, sell, and sublicense products practicing the patents. But the patent owners retained several important rights:

    • the right to sue infringers;
    • shared control over infringement litigation;
    • veto authority over sublicenses;
    • ongoing royalty interests;
    • patent prosecution control;
    • termination rights for material breach; and
    • limited retained practice rights.

    When A.L.M. and Ergon later sued Zydex for infringement, the district court dismissed the case for lack of Article III standing, concluding that the retained rights were insufficiently “exclusionary.”

    The Federal Circuit reversed.

    The Court Reemphasizes the Difference Between Constitutional and Statutory Standing

    One of the most significant aspects of the opinion is its careful separation of constitutional standing from statutory standing.

    The Federal Circuit explained that Article III standing concerns whether the plaintiff has suffered a constitutionally cognizable injury-in-fact. By contrast, statutory standing under § 281 asks whether the plaintiff qualifies as a “patentee” entitled to sue.

    That distinction matters because statutory defects are often curable through joinder, while constitutional standing defects are jurisdictional and fatal if absent at the outset.

    The court acknowledged that prior Federal Circuit decisions had sometimes “melded” these inquiries together, creating confusion for district courts attempting to evaluate standing in complicated licensing arrangements.

    Charles Gideon Korrell notes that this portion of the opinion may become one of its most cited sections because district courts frequently collapse the “all substantial rights” analysis into the Article III inquiry without adequately distinguishing the separate legal questions involved.

    The panel emphasized that a patent owner can retain constitutional standing even if it transferred away enough rights that it might no longer independently satisfy the “all substantial rights” test for statutory standing.

    That clarification alone likely narrows a line of increasingly aggressive standing challenges that defendants have used in patent cases involving complex licensing structures.

    Why the Retained Rights Were Enough

    The Federal Circuit ultimately concluded that the licensors retained a sufficient “exclusionary right” to establish Article III standing.

    The court focused on three interconnected retained rights:

    1. the retained right to sue;
    2. veto authority over sublicenses; and
    3. continuing royalty interests.

    The sublicensing veto proved particularly important. Ingevity could not freely sublicense the patents without the patent owners’ consent, and any sublicense remained subject to royalty obligations flowing back to the patent owners.

    That structure prevented the licensee from unilaterally extinguishing the patent owners’ enforcement rights through royalty-free sublicenses to accused infringers.

    The Federal Circuit characterized this as preserving a genuine exclusionary interest rather than a merely theoretical or “illusory” right.

    The court repeatedly returned to the idea that the retained enforcement rights had real economic and practical substance. Because infringement deprived the patent owners of royalties and because the licensors maintained meaningful control over sublicensing and enforcement, they retained a concrete stake sufficient for constitutional standing.

    The Court’s Reliance on Alfred E. Mann

    The opinion heavily relies on Alfred E. Mann Foundation for Scientific Research v. Cochlear Corp., a case often associated with statutory standing rather than constitutional standing.

    That reliance is important.

    The district court had treated Mann as largely irrelevant because it involved the “all substantial rights” doctrine under § 281. The Federal Circuit rejected that approach and explained that factual analyses underlying statutory standing cases may still inform the constitutional inquiry.

    Specifically, the panel emphasized Mann’s discussion regarding whether a retained right to sue is “illusory.”

    Under Mann, a patent owner’s retained enforcement rights are not illusory where:

    • the licensee cannot freely sublicense accused infringers;
    • royalty interests remain protected; and
    • the patent owner maintains meaningful enforcement participation.

    Those same features existed here.

    Charles Gideon Korrell believes the opinion significantly strengthens the continuing vitality of Mann in modern standing disputes, particularly in cases involving sophisticated licensing arrangements common in the pharmaceutical, semiconductor, and industrial technology sectors.

    Distinguishing Morrow v. Microsoft

    The panel also carefully distinguished Morrow v. Microsoft, which defendants frequently cite in standing disputes.

    In Morrow, the plaintiff possessed only a bare contractual right to sue, divorced from ownership and stripped of meaningful exclusionary interests.

    That was not the situation here.

    Unlike the plaintiff in Morrow, A.L.M. and Ergon:

    • still owned the patents;
    • retained royalty interests;
    • maintained control over sublicensing;
    • preserved litigation participation rights; and
    • could prevent royalty-free sublicenses to accused infringers.

    The Federal Circuit emphasized that Morrow involved a “bare right to sue,” whereas the patent owners here retained multiple interlocking economic and enforcement interests tied directly to the patents themselves.

    That distinction may prove highly consequential in future standing challenges.

    Broader Implications for Patent Licensing

    The decision provides practical drafting guidance for licensors who want to preserve standing after granting broad exclusive rights.

    Several retained rights appear especially significant after this opinion:

    • retained approval authority over sublicenses;
    • continuing royalty participation;
    • meaningful enforcement participation rights;
    • retained ability to initiate litigation; and
    • restrictions preventing royalty-free sublicensing.

    The court repeatedly suggested that these provisions collectively preserved a real exclusionary interest rather than a merely symbolic one.

    By contrast, the opinion implies that standing risks increase when:

    • the licensee can freely sublicense accused infringers;
    • the patent owner lacks royalty participation;
    • enforcement authority is entirely transferred; or
    • the retained rights exist only nominally.

    Charles Gideon Korrell notes that many older license agreements were drafted primarily around the “all substantial rights” framework without carefully considering the separate constitutional standing inquiry. This decision may prompt companies to revisit existing agreements, particularly where litigation is anticipated.

    The Decision’s Impact on Litigation Strategy

    The opinion may also affect litigation tactics.

    Over the last decade, accused infringers increasingly used standing challenges as an early procedural weapon, particularly after Lone Star and Lexmark reshaped portions of the standing analysis.

    Some defendants pushed for highly restrictive interpretations of constitutional standing, especially where patent ownership structures involved layered licenses, enforcement entities, or field-of-use arrangements.

    This decision pushes back against that trend.

    The Federal Circuit rejected an overly rigid approach that would have required patent owners to retain near-complete control in order to satisfy Article III. Instead, the court reaffirmed that the constitutional inquiry focuses on whether the plaintiff retains a concrete exclusionary interest, not whether it retained every commercially significant patent right.

    That distinction is likely to matter in:

    • technology transfer agreements;
    • university licensing structures;
    • private equity-backed patent monetization programs;
    • cross-licensing arrangements;
    • joint venture commercialization models; and
    • field-restricted exclusive licenses.

    The opinion may be especially important in industries where commercialization and enforcement responsibilities are intentionally separated between operating companies and patent-holding entities.

    A Continuing Cleanup of Federal Circuit Standing Doctrine

    Viewed more broadly, the case represents another step in the Federal Circuit’s continuing effort to rationalize patent standing doctrine after years of doctrinal overlap.

    The court openly acknowledged that its own precedents contributed to confusion by “melding” constitutional and statutory analyses together.

    This opinion attempts to restore analytical discipline by:

    • distinguishing Article III injury from § 281 entitlement;
    • clarifying that factual overlap does not collapse the doctrines;
    • reaffirming the importance of retained exclusionary rights; and
    • rejecting bright-line rules based solely on exclusive licensing status.

    For patent litigators, the opinion will likely become a frequently cited authority in future standing disputes involving exclusive licenses.

    For transactional lawyers, it offers a useful blueprint for preserving enforcement flexibility without undermining commercial exclusivity.

    And for district courts, the decision provides clearer direction on how to analyze retained patent rights without conflating constitutional standing with statutory standing doctrine.

    By Charles Gideon Korrell

  • Ingevity v. BASF: Federal Circuit Affirms $84.8M Antitrust Verdict for Patent-Based Tying of Staple Goods

    Ingevity v. BASF: Federal Circuit Affirms $84.8M Antitrust Verdict for Patent-Based Tying of Staple Goods

    On February 11, 2026, the Federal Circuit in Ingevity Corp. v. BASF Corp., No. 2024-1577, affirmed a jury verdict finding unlawful tying under the Sherman Act and upholding a $28.3 million damages award (trebled to approximately $84.8 million).

    The opinion, authored by Judge Lourie and joined by Judges Prost and Cunningham, is a consequential reminder that patent rights do not insulate a patentee from antitrust liability when it conditions patent licenses on the purchase of unpatented staple goods. It also clarifies the interaction between 35 U.S.C. § 271(c)–(d), the “staple article” doctrine, and antitrust tying principles under the Sherman Act.

    Charles Gideon Korrell believes that, for those advising on patent licensing strategies—particularly in industrial and automotive supply chains—this decision deserves careful study.


    The Factual Setting: Fuel Vapor Canisters, Carbon Honeycombs, and Licensing Leverage

    Ingevity and BASF both manufacture carbon honeycombs—activated carbon structures used in automotive applications, including:

    • Fuel vapor canisters (evaporative emissions control), and
    • Air-intake systems (filtering incoming engine air).

    Ingevity owned U.S. Patent RE38,844, directed to a dual-stage fuel vapor canister system. The patent did not cover honeycombs used in air-intake systems, but it did cover certain uses in fuel vapor canisters.

    BASF introduced a competing honeycomb product (EvapTrap XC). Ingevity sued for patent infringement. BASF counterclaimed, alleging:

    • Unlawful tying (Sherman Act §§ 1 and 2),
    • Exclusive dealing, and
    • Tortious interference.

    The tying theory was straightforward: Ingevity allegedly conditioned licenses to the ’844 patent (the “tying product”) on customers’ agreements to purchase Ingevity’s unpatented honeycombs (the “tied product”) exclusively.

    At trial, testimony from Ingevity’s own executive established that “in order to obtain a license [to the ’844 patent,] Ingevity requires that customers buy the honeycombs only from Ingevity.”

    As Charles Gideon Korrell notes, that testimony proved pivotal.


    The Patent Misuse Defense: The Staple vs. Nonstaple Divide

    Ingevity’s principal defense rested on 35 U.S.C. § 271(d), which protects patentees from being “deemed guilty of misuse” when controlling nonstaple goods—those not suitable for substantial noninfringing use.

    The statutory structure is familiar:

    • § 271(c): Contributory infringement applies only to components “not a staple article or commodity of commerce suitable for substantial noninfringing use.”
    • § 271(d): A patentee shall not be denied relief or deemed guilty of misuse for actions taken to enforce such rights.

    The Supreme Court in Dawson Chemical Co. v. Rohm & Haas Co., 448 U.S. 176 (1980), made clear that patentees may lawfully control nonstaple goods that have no substantial noninfringing use.

    Ingevity argued that its honeycombs were nonstaple and thus lawfully subject to control—even if that control suppressed competition in an unpatented goods market.

    The jury rejected that premise.


    Substantial Evidence of Staple Goods

    The central factual question was whether Ingevity’s honeycombs had “actual and substantial noninfringing uses.” The Federal Circuit affirmed the jury’s finding that they did.

    1. Documentary Sales Evidence

    BASF introduced Ingevity’s own internal records showing repeated sales of honeycombs for air-intake systems (a concededly noninfringing use), totaling more than 18,000 units across multiple years.

    Ingevity claimed those records were typographical errors. The jury was free to disbelieve that explanation—particularly where no corroborating evidence supported it.

    2. Technical Evidence

    BASF relied on:

    • The Park patent (covering Ingevity’s honeycomb manufacturing process), which disclosed air-intake use as an intended application, and
    • Expert testimony establishing suitability for air-intake systems.

    Ingevity offered no competing expert testimony demonstrating technical impossibility.

    3. “Substantial” Does Not Mean Majority

    Ingevity argued that 18,000 units were not “substantial” relative to total sales. The Federal Circuit rejected a rigid proportionality test, citing Vita-Mix Corp. v. Basic Holding, Inc., 581 F.3d 1317 (Fed. Cir. 2009), and In re Bill of Lading Transmission & Processing Sys. Patent Litig., 681 F.3d 1323 (Fed. Cir. 2012).

    “Substantial” does not require majority usage. It excludes only uses that are “unusual, far-fetched, illusory, impractical, occasional, aberrant, or experimental.”

    Recurring, commercially viable noninfringing uses met the standard.

    Once the product was deemed a staple, § 271(d) no longer shielded the tying conduct.


    Immunity: Noerr-Pennington and the Failed Reframing

    Ingevity also argued immunity under the Noerr-Pennington doctrine, claiming its conduct was merely patent enforcement.

    But the jury instructions explicitly distinguished:

    • Protected patent communications, from
    • Unlawful tying or exclusive dealing beyond the scope of the patent monopoly.

    By finding unlawful tying, the jury necessarily found conduct beyond mere enforcement.

    On appeal, Ingevity attempted to reframe its argument, asserting that even actual tying of staple goods was immune under Rohm & Haas. The Federal Circuit held this theory forfeited and unsupported.

    Charles Gideon Korrell notes that the court emphasized that no authority extends immunity to classic commercial tying conduct merely because a patent is involved.


    Antitrust Framework: Classic Tying

    Under Third Circuit law (applied here), tying requires:

    1. Two distinct products,
    2. Market power in the tying product, and
    3. A substantial effect on interstate commerce.

    The court cited Jefferson Parish Hospital Dist. No. 2 v. Hyde, 466 U.S. 2 (1984), and Illinois Tool Works Inc. v. Independent Ink, Inc., 547 U.S. 28 (2006), reinforcing that patent ownership does not automatically establish market power—but neither does it immunize leveraging that power into adjacent markets.

    Even a lawfully obtained patent monopoly cannot be expanded to control staple goods outside the patent’s scope.


    Damages: No Mandatory Disaggregation

    The jury awarded $28.3 million (trebled).

    Ingevity argued BASF failed to disaggregate damages attributable to unlawful tying from those caused by lawful patent enforcement.

    The Federal Circuit rejected that argument, citing:

    A plaintiff need only show that unlawful conduct was a “material or substantial cause” of injury.

    Where unlawful and lawful conduct are intertwined, the defendant “bears the risk of the uncertainty which [its] own wrong has created.”

    The jury was entitled to credit BASF’s expert testimony that disaggregation was infeasible.


    Strategic Takeaways

    Charles Gideon Korrell sees this case carrying several significant implications.

    1. Staple Goods Are a Dangerous Lever. If a component has substantial noninfringing uses, tying it to patent licenses is high-risk. The § 271(d) safe harbor evaporates.
    2. Internal Records Matter. Ingevity’s own spreadsheets and memos proved decisive. Internal “end use” designations can become antitrust evidence years later.
    3. Expert Silence Is Costly. Ingevity offered no technical expert to refute suitability for air-intake systems. The absence of rebuttal evidence allowed the jury to accept BASF’s narrative.
    4. Immunity Arguments Must Be Preserved. The Federal Circuit’s forfeiture holding underscores the importance of maintaining consistent legal theories from summary judgment through appeal.
    5. Damages Models Need Not Be Perfect. When unlawful tying affects price, access, and competitive positioning simultaneously, courts may permit aggregated damages models.

    The Mooted Patent Invalidity Issue

    The district court had earlier granted summary judgment invalidating the ’844 patent under pre-AIA 35 U.S.C. § 102(g). The Federal Circuit did not reach that issue.

    Because the jury’s tying verdict rendered the patent unenforceable—and the patent expired during appeal—the invalidity question was moot.


    Broader Implications for Licensing Strategy

    Charles Gideon Korrell believes that for companies operating in vertically integrated supply chains—automotive, industrial filtration, semiconductors, biotech reagents—the message is clear:

    • Conditioning licenses on exclusive purchases of staple components can trigger Sherman Act liability.
    • Patent enforcement communications are protected; commercial tying conduct is not.
    • Section 271(d) is a shield only when the tied product is truly nonstaple.

    This opinion reinforces the long-standing principle that patent rights define the boundary of lawful exclusion—and that stepping beyond that boundary can transform intellectual property leverage into antitrust exposure.

    The Federal Circuit’s analysis carefully harmonizes patent misuse doctrine, contributory infringement law, and antitrust tying jurisprudence without expanding immunity doctrines beyond established precedent.

    For practitioners structuring licensing programs, careful product classification analysis and clean separation of patent rights from commercial supply obligations are essential.


    The Federal Circuit’s decision in Ingevity Corp. v. BASF Corp. stands as a powerful reminder that the line between aggressive patent licensing and unlawful tying is policed not just by misuse doctrine—but by federal antitrust law itself.

    By Charles Gideon Korrell

  • Court Upholds Limited Damages in Bitmanagement Software GmbH v. United States: Key Takeaways on Copyright Infringement and Licensing

    On January 7, 2025, the United States Court of Appeals for the Federal Circuit issued its decision in Bitmanagement Software GmbH v. United States, affirming a damages award of $154,400 for copyright infringement by the U.S. Navy. The case centered around the Navy’s unauthorized copying and use of Bitmanagement’s 3D rendering software, BS Contact Geo, raising significant issues in copyright law, licensing agreements, and damages calculations.

    Background of the Case

    Bitmanagement, a German software company, initially licensed BS Contact Geo to the Navy in 2008 through seat licenses, which restricted installation to specific computers. In 2012, the parties transitioned to a floating license model, which allowed broader access but required monitoring software (Flexera) to enforce concurrent usage limits. However, the Navy later installed the software on over 429,000 computers without ensuring compliance with the agreed usage restrictions.

    After discovering this breach, Bitmanagement sued the U.S. government for copyright infringement in 2016, leading to a complex litigation over the scope of the Navy’s license and the appropriate damages for the unauthorized copying.

    Major Legal Issues Addressed

    1. Implied License and Copyright Infringement

    One of the core disputes was whether the Navy’s actions constituted copyright infringement or were covered by an implied license. The Court of Federal Claims initially ruled in favor of the Navy, holding that an implied license existed. However, on appeal, the Federal Circuit clarified that while an implied license was granted, it was conditioned on the use of Flexera to track and limit concurrent use. Since the Navy failed to implement this safeguard, its conduct amounted to copyright infringement.

    2. Method of Calculating Damages

    A crucial issue in the case was the method for calculating damages under 28 U.S.C. § 1498(b), which governs copyright infringement claims against the U.S. government. Bitmanagement argued that it should be compensated based on a per-copy basis, amounting to approximately $85.9 million, as the Navy had installed the software on 429,567 computers.

    The Court, however, applied the Gaylord v. United States precedent, which mandates that damages in such cases should reflect a hypothetical negotiation at the time of the infringement. The Court reasoned that because Bitmanagement had previously agreed to floating licenses—where charges were based on concurrent users rather than installations—the hypothetical negotiation would have led to a license fee based on usage rather than per-copy sales.

    3. Burden of Proof on Usage

    The ruling also addressed the burden of proof regarding the Navy’s actual use of the software. The Federal Circuit held that, as the party that breached the licensing agreement, the Navy bore the burden of proving its actual software usage. However, the Court found that Bitmanagement had not sufficiently challenged the government’s usage estimates and did not provide alternative damages calculations.

    4. Admissibility of Expert Testimony

    Bitmanagement challenged the admission of testimony from the government’s expert, David Kennedy, who estimated damages based on Navy usage data. The Court upheld his testimony, finding it credible and aligned with standard methodologies for determining copyright damages in government infringement cases.

    Implications for Intellectual Property and Government Licensing

    1. Importance of Clear Licensing Terms

    This case underscores the importance of well-defined licensing agreements, particularly for software providers dealing with government entities. The failure to enforce explicit monitoring and usage restrictions allowed the Navy to argue for a more limited interpretation of damages.

    2. Challenges in Proving Damages

    The decision highlights the difficulties in proving damages for software infringement, especially when a floating license model is involved. Companies should maintain detailed records of negotiations and enforce monitoring mechanisms to strengthen potential claims in litigation.

    3. Limits on Government Copyright Liability

    Under Gaylord, the Court reaffirmed that copyright damages against the government are limited to “reasonable and entire compensation,” which does not necessarily equate to commercial licensing rates in the private sector. This means companies contracting with the government should anticipate that damages may be awarded based on actual use rather than theoretical maximum exposure.

    Conclusion

    The Federal Circuit’s decision in Bitmanagement Software GmbH v. United States sets a precedent for how copyright damages are calculated in government infringement cases. By affirming a relatively modest damages award, the Court reinforced the principle that compensation should reflect a reasonable licensing negotiation rather than punitive measures. For intellectual property owners, the ruling serves as a reminder to establish clear contractual safeguards and proactively enforce licensing terms to avoid disputes over implied use and damages calculations.

    By Charles Gideon Korrell